Drug recall · June 20, 2012
Diazepam Injection recall
Why: Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.
- Lots / codes
Lot #: 8D1082, Exp 01/13; 8D1151, Exp 03/13
- Quantity
- 83,400 autoinjectors
- Company
- Meridian Medical Technologies a Pfizer Company, Saint Louis, MO
- Distribution
- Nationwide, military, Italy, Singapore, Sweden, and Canada.
- Initiated
- June 6, 2012 · Voluntary: Firm initiated
- Classified
- June 11, 2012
- Reported
- June 20, 2012
- Ended
- August 5, 2013
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.